Antigen-specific CD8+ T cells are activated after recognizing tumor-associated antigens presented by MHC class I (MHC I) molecules, and an immune synapse is formed between the target tumor cells and CD8+ T cells of high functional and structural avidity that preferentially reside in tumors [15]. Here, CD8A is linked to neoplasm.